Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 022239
Company: ENDO OPERATIONS

• Summary Review

Products on NDA 22239

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
SUMAVEL DOSEPRO	SUMATRIPTAN SUCCINATE	EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)	SOLUTION;SUBCUTANEOUS	Discontinued	None	Yes	No
SUMAVEL DOSEPRO	SUMATRIPTAN SUCCINATE	EQ 4MG BASE/0.5ML (EQ 8MG BASE/ML)	SOLUTION;SUBCUTANEOUS	Discontinued	None	Yes	No

Labels for NDA 022239

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
07/02/2020	SUPPL-7	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022239s007lbl.pdf
12/26/2019	SUPPL-6	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022239s006lbl.pdf
06/02/2016	SUPPL-4	Manufacturing (CMC)	Label (PDF)	This supplement type does not usually require new labeling.	https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022239s004lbl.pdf
11/26/2013	SUPPL-5	Efficacy-Manufacturing Change With Clinical Data	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022239s005lbl.pdf
06/27/2011	SUPPL-2	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022239s002lbl.pdf
07/15/2009	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022239lbl.pdf